Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Genetic changes of CEBPA in cancer: Mutations or polymorphisms?
Publication

Publications

Genetic changes of CEBPA in cancer: Mutations or polymorphisms?

Title
Genetic changes of CEBPA in cancer: Mutations or polymorphisms?
Type
Another Publication in an International Scientific Journal
Year
2007
Authors
Resende, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Regalo, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Duraes, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Machado JC
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 25
Pages: 2493-2494
ISSN: 0732-183X
Other information
Authenticus ID: P-004-9D5
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 2
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBP beta-associated mechanism (2016)
Article in International Scientific Journal
Resende, C; Regalo, G; Duraes, C; Pinto, MT; Wen, XG; Figueiredo C; Carneiro F; Machado JC
C/EBP alpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis (2010)
Article in International Scientific Journal
Regalo, G; Resende, C; Wen, XG; Gomes, B; Duraes, C; Seruca, R; Carneiro F; Machado JC

Of the same journal

Comparative cost-effectiveness analysis of avelumab plus axitinib versus pembrolizumab plus axitinib, ipilimumab plus nivolumab, and sunitnib for advanced renal cell carcinoma in the UK Perspective (2020)
Another Publication in an International Scientific Journal
De Mello, RA; Ayoub, E; Castelo Branco, P; De Almeida Zia, VAD; Savio, A; Daniel Pozza; Tadokoro, H; Teich, N
Coexistence of TERT Promoter and BRAF Mutations in Papillary Thyroid Carcinoma: Added Value in Patient Prognosis? (2015)
Another Publication in an International Scientific Journal
Miguel Melo; Adriana Gaspar da Rocha; Joao Vinagre; Manuel Sobrinho Simoes; Paula Soares
Age-Associated Mortality Risk in Papillary Thyroid Cancer: Does BRAF Make a Real Difference? (2018)
Another Publication in an International Scientific Journal
Melo, M; Gaspar da Rocha, A; Cancela e Penna, G; Sobrinho Simoes, M; Soares, P
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores (2017)
Article in International Scientific Journal
Nathanson, KL; Domchek, SM; Lorenchick, C; Jankowitz, RC; Campbell, I; James, P; Mitchell, G; Orr, N; Park, SK; Thomassen, M; Offit, K; Couch, FJ; Simard, J; Easton, DF; Chenevix Trench, G; Schmutzler, RK; Antoniou, AC; Ottini, L; Lecarpentier, J; Silvestri, V...(mais 157 authors)
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline (2019)
Article in International Scientific Journal
Yarom, N; Shapiro, CL; Peterson, DE; Van Poznak, CH; Bohlke, K; Ruggiero, SL; Migliorati, CA; Khan, A; Morrison, A; Anderson, H; Murphy, BA; Alston Johnson, D; Mendes, RA; Beadle, BM; Jensen, SB; Saunders, DP

See all (6)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-13 at 01:30:11 | Privacy Policy | Personal Data Protection Policy | Whistleblowing